tiprankstipranks
Trending News
More News >
Draegerwerk AG & Co. KGaA (DE:DRW3)
XETRA:DRW3
Advertisement

Draegerwerk AG & Co. KGaA (DRW3) AI Stock Analysis

Compare
9 Followers

Top Page

DE:DRW3

Draegerwerk AG & Co. KGaA

(XETRA:DRW3)

Select Model
Select Model
Select Model
Neutral 63 (OpenAI - 4o)
Rating:63Neutral
Price Target:
€71.00
▲(8.40% Upside)
Draegerwerk AG & Co. KGaA's overall stock score reflects a stable financial position with challenges in revenue growth and cash generation. The technical analysis indicates a neutral to slightly bearish outlook, while the valuation is attractive with a reasonable P/E ratio and a solid dividend yield. The absence of earnings call data and corporate events means these factors do not influence the score.
Positive Factors
Negative Factors

Draegerwerk AG & Co. KGaA (DRW3) vs. iShares MSCI Germany ETF (EWG)

Draegerwerk AG & Co. KGaA Business Overview & Revenue Model

Company DescriptionDrägerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, system products, and other services. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as fire training facilities for firefighters. Drägerwerk AG & Co. KGaA was founded in 1889 and is headquartered in Lübeck, Germany.
How the Company Makes MoneyDraegerwerk generates revenue through the sale of its medical and safety products, which are distributed globally to hospitals, healthcare institutions, and industrial companies. Key revenue streams include direct sales of medical devices and safety equipment, service contracts for maintenance and support, and consumables associated with their products. The company also benefits from partnerships with healthcare providers and governmental agencies that bolster its market presence and facilitate access to new clients. Additionally, Draegerwerk invests in research and development to innovate and expand its product offerings, which helps maintain a competitive edge and drives future earnings.

Draegerwerk AG & Co. KGaA Financial Statement Overview

Summary
Draegerwerk AG & Co. KGaA shows a stable financial position with challenges. The income statement indicates declining revenue and profitability margins. The balance sheet is strong with low leverage, but cash flow metrics reveal potential issues in cash generation, impacting future financial flexibility.
Income Statement
65
Positive
The income statement shows a mixed performance. The gross profit margin remains stable at around 45%, indicating efficient cost management. However, the net profit margin has decreased slightly to 3.42% in the TTM, reflecting pressure on profitability. Revenue growth is negative at -13.9% TTM, suggesting challenges in maintaining sales momentum. EBIT and EBITDA margins have also declined, indicating reduced operational efficiency.
Balance Sheet
70
Positive
The balance sheet is relatively strong with a debt-to-equity ratio of 0.26, indicating a conservative leverage position. Return on equity is modest at 7.89%, showing decent profitability relative to shareholder equity. The equity ratio is stable, suggesting a solid capital structure. However, the slight decline in stockholders' equity over time could be a concern if it continues.
Cash Flow
60
Neutral
Cash flow analysis reveals some weaknesses. Free cash flow growth is negative, indicating potential issues in generating cash from operations. The operating cash flow to net income ratio is low at 0.17, suggesting limited cash conversion efficiency. However, the free cash flow to net income ratio is relatively healthy at 0.62, indicating some ability to generate cash relative to net income.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue3.36B3.37B3.37B3.05B3.33B3.41B
Gross Profit1.51B1.51B1.46B1.24B1.54B1.61B
EBITDA315.73M351.68M318.33M62.63M374.43M399.92M
Net Income99.86M124.41M110.43M-64.56M154.23M188.59M
Balance Sheet
Total Assets2.99B3.09B3.09B3.11B3.18B3.31B
Cash, Cash Equivalents and Short-Term Investments218.91M248.18M279.36M319.50M577.38M650.56M
Total Debt446.92M395.58M471.38M361.95M348.01M370.75M
Total Liabilities1.52B1.56B1.69B1.79B1.92B2.27B
Stockholders Equity1.46B1.54B1.41B1.32B1.26B1.03B
Cash Flow
Free Cash Flow122.22M103.52M121.47M-231.09M274.54M345.04M
Operating Cash Flow190.64M167.31M189.68M-144.23M384.89M459.98M
Investing Cash Flow-92.53M-43.39M-67.34M36.83M-109.92M-263.08M
Financing Cash Flow-103.70M-161.38M-154.56M-29.38M-334.64M114.25M

Draegerwerk AG & Co. KGaA Technical Analysis

Technical Analysis Sentiment
Negative
Last Price65.50
Price Trends
50DMA
67.91
Negative
100DMA
67.08
Negative
200DMA
60.19
Positive
Market Momentum
MACD
-0.56
Positive
RSI
40.01
Neutral
STOCH
23.23
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:DRW3, the sentiment is Negative. The current price of 65.5 is below the 20-day moving average (MA) of 67.08, below the 50-day MA of 67.91, and above the 200-day MA of 60.19, indicating a neutral trend. The MACD of -0.56 indicates Positive momentum. The RSI at 40.01 is Neutral, neither overbought nor oversold. The STOCH value of 23.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DE:DRW3.

Draegerwerk AG & Co. KGaA Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
52.61B24.3512.29%2.01%5.85%16.20%
67
Neutral
1.26B67.745.34%0.21%1.16%-43.53%
66
Neutral
12.57B19.334.95%3.33%0.53%23.79%
63
Neutral
€1.10B12.306.87%3.10%-0.03%-14.15%
60
Neutral
3.98B25.148.75%1.35%5.21%-39.36%
44
Neutral
1.11B-7.16-18.39%-1.41%9.05%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DE:DRW3
Draegerwerk AG & Co. KGaA
65.50
22.26
51.49%
GB:0DHC
Carl Zeiss Meditec
44.61
-13.34
-23.02%
GB:0MSD
CompuGroup Medical
23.92
10.55
78.91%
GB:0IRF
Evotec
6.24
0.48
8.33%
GB:0H9X
Fresenius Medical Care AG & Co. KGaA
43.26
7.82
22.07%
SEMHF
Siemens Healthineers AG
56.70
3.96
7.51%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 06, 2025